Commentary

Understanding ovarian germ cell neoplasms


 

References

Dr. Gehrig is professor and director of gynecologic oncology at the University of North Carolina at Chapel Hill. Dr. Castellano is a resident physician in the obstetrics and gynecology program at the university. They reported having no relevant financial disclosures. To comment, email them at obnews@frontlinemedcom.com.

Pages

Recommended Reading

Minimally invasive and abdominal hysterectomy yield similar results for endometrial cancer
MDedge Hematology and Oncology
Report: Heterogeneity of ovarian cancer should drive research, treatment
MDedge Hematology and Oncology
Obesity, oral contraceptive use are risk factors for cerebral venous thrombosis in women
MDedge Hematology and Oncology
Case may be building for annual CA-125 ovarian cancer screening
MDedge Hematology and Oncology
Observation might be best in advanced-stage, low-grade ovarian CA
MDedge Hematology and Oncology
Gynecologic oncologists often missing from pediatric pelvic evaluations
MDedge Hematology and Oncology
College students report perceived barriers to HPV vaccine
MDedge Hematology and Oncology
New vulvar cancer guidelines stress regional disease control
MDedge Hematology and Oncology
Bone marrow transplant cures severe HPV disease in GATA2 immunodeficiency
MDedge Hematology and Oncology
Premenopausal age linked to lower sexual function after gynecologic cancer surgery
MDedge Hematology and Oncology